The IPO Buzz: LandBridge (LB Proposed) Sets Terms for $297.3 Million IPO

LandBridge Co LLC (LB Proposed), a Houston-based company that buys and manages oil- and natural gas-rich land in the Permian Basin, unveiled the terms for its $297.25 million IPO in an S-1/A filing early  today  – Monday, June 17, 2024.  The IPO is expected to price late next week. (Please see the IPO Calendar on IPOScoop.com […]

Read More

The IPO Buzz: SPAC Perceptive Capital Solutions Raises $75 Million

Perceptive Capital Solutions Corp. (PCSC), a small healthcare SPAC based in New York, raised $75 million with the pricing of its small stock-only IPO on Tuesday night, June 11, 2024. The SPAC – sponsored by an affiliate of Perceptive Advisors – sold 7.5 million shares at $10.00 each. Perceptive Capital Solutions Corp.’s stock closed at […]

June 12, 2024 Read More

The IPO Buzz: Centurion Acquisition Raises $250 Million in SPAC IPO

Centurion Acquisition Corp. (ALFUU) priced its SPAC IPO of 25.0 million units at $10.00 each – the terms in the prospectus – to raise $250.0 million on Monday night, June 10, 2024. Each unit consists of one Class A share of common stock and one-half warrant. Centurion Acquisition’s stock rose in its NASDAQ debut to […]

June 11, 2024 Read More

The IPO Buzz: Cancer-Focused Tempus AI (TEM Proposed) Leads $616 Million Week

Tempus AI (TEM Proposed), known for its proprietary AI-driven healthcare data platform, leads the IPO Calendar for the second week of June with its $400 million IPO. The unprofitable cancer-focused genomics testing and data company’s IPO  is the only big IPO on this week’s lineup. Tempus AI is backed by SoftBank Corp. of Japan. Australia’s […]

June 9, 2024 Read More

The IPO Buzz: Rapport Therapeutics (RAPP) Prices IPO at $17.00 Mid-Point

Rapport Therapeutics (RAPP), a Phase II biotech, priced its IPO at $17.00 – the mid-point of its $16.00-to-$18.00 range – on 8.0 million shares – the number in the prospectus – to raise $136.0 million, the company said on Thursday night, June 6, 2024. Shares of Rapport Therapeutics jumped $1.00 from their IPO price to open at […]

June 6, 2024 Read More
Page 3 of 11512345...102030...Last »